Aiming to Improve the Treatment of Solid Tumors NanOlogy is advancing a local precision approach aimed at improving the treatment of solid tumors without adding toxicity and enabled by the Purcision TM particle engineering technology that forms unique drug microparticles designed for intratumoral delivery. The patented large surface area microparticles (LSAMs) of pure drug remain at the disease site as a depot continuously releasing drug at high local concentration but with negligible systemic levels and to
NanOlogy Clinical and Preclinical Immune Data Presented at NACLC and SITC
NanOlogy Announces an Abstract Has Been Accepted for Presentation at the IASLC North America Conference on Lung Cancer